This content is machine translated COPD Which patients benefit from ICS as an add-on? The eosinophil count in the blood (EOS) is considered a suitable biomarker for deciding whether COPD patients are likely to derive additional clinical benefit from inhaled steroids (ICS) as an…
View Post 5 min This content is machine translated Systemic lupus erythematosus (SLE) Besides Belimumab, other biologics soon available for the treatment of SLE? The therapeutic options available today allow the choice of an individualized therapeutic strategy. In addition to covventional immunosuppressants, biologics are becoming increasingly important. Belimumab has been approved as an add-on…
